- Artículo
- Fuente: Campus Sanofi
- 7 abr 2025
Pósters presentados en el 21st WORLDSymposium
En esta edición, destacados expertos han compartido investigaciones innovadoras que abordan el diagnóstico, tratamiento y manejo de diversas enfermedades lisosomales.
Accede a los pósters clasificados por patologías y explora las videograbaciones de los autores, donde explican sus hallazgos más relevantes.
Gaucher y ASMD

Project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA-2)

Clinical variability in Gaucher disease associated with the c.1880T>G (D409H) variant in GBA1

Efficacy of Eliglustat Administered With and Without Imiglucerase in Pediatric Participants With Gaucher Disease Type 1 or Type 3: The ELIKIDS Study

Predictive model for estimating the risk of bone mineral loss in Gaucher disease

Exploring the correlation between miRNA and osteonecrosis in Gaucher disease

Design of PROMs and PREMs questionnaire for ASMD care

Project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA-2)

Clinical variability in Gaucher disease associated with the c.1880T>G (D409H) variant in GBA1

Efficacy of Eliglustat Administered With and Without Imiglucerase in Pediatric Participants With Gaucher Disease Type 1 or Type 3: The ELIKIDS Study

Predictive model for estimating the risk of bone mineral loss in Gaucher disease

Exploring the correlation between miRNA and osteonecrosis in Gaucher disease

Design of PROMs and PREMs questionnaire for ASMD care
Videograbaciones
Lisosomales

Lipid profiling in dried blood spots: A tool for diagnosing lysosomal storage disorders

Validation of "in silico" predictors for analyzing variants of uncertain significance in lysosomal storage disorders

Understanding the role of neutrophil extracellular traps in vascular complications of lysosomal disorders

Retrospective study to analyze and validate a set of potential predictive markers to identify lysosomal acid lipase deficiency

Evaluating lipocalin-2 as a biomarker for lysosomal acid lipase deficiency

Lipid profiling in dried blood spots: A tool for diagnosing lysosomal storage disorders

Validation of "in silico" predictors for analyzing variants of uncertain significance in lysosomal storage disorders

Understanding the role of neutrophil extracellular traps in vascular complications of lysosomal disorders

Retrospective study to analyze and validate a set of potential predictive markers to identify lysosomal acid lipase deficiency

Evaluating lipocalin-2 as a biomarker for lysosomal acid lipase deficiency
Videograbaciones
MPS

Long-term outcome of Mucopolysaccharidosis I-Hurler patients after hematopoietic cell transplantation

Oral therapy for lisosomal diseases

Long-term outcome of Mucopolysaccharidosis I-Hurler patients after hematopoietic cell transplantation

Oral therapy for lisosomal diseases
Videograbaciones
Neuromuscular

Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease

Reversible deficiencies of arylsulfatase B and alpha-galactosidase in Duchenne muscular dystrophy (DMD)

Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease

Reversible deficiencies of arylsulfatase B and alpha-galactosidase in Duchenne muscular dystrophy (DMD)
Videograbaciones

MAT-ES-2500712 V1 ABRIL 2025